Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Ecs Botanics Holdings Ltd ( (AU:ECS) ) just unveiled an update.
ECS Botanics Holdings Ltd reported significant growth in its direct-to-consumer (B2C) sales, which increased by 20% quarter-on-quarter, now representing 53% of the company’s total sales. The company achieved a record harvest, yielding 10.6 tonnes of untrimmed dried flower, and expanded its product portfolio with the launch of Terphogz premium flower strains. ECS also improved its financial flexibility by increasing its corporate loan facility, positioning itself among the top 15 medicinal cannabis brands in Australia.
More about Ecs Botanics Holdings Ltd
ECS Botanics Holdings Ltd is a leading medicinal cannabis company that focuses on producing and selling cannabis products. The company offers a diverse range of products, including capsules, oils, pastilles, and flower, and is committed to leveraging its Australian-grown, organic credentials to enhance product differentiation and patient outcomes.
Average Trading Volume: 1,693,298
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$11.66M
For a thorough assessment of ECS stock, go to TipRanks’ Stock Analysis page.